Skip to main content

Table 5 Results from assessment of precipitation in TPNaq

From: Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs

TPNaq

Drug

Time after mixing h

Light obscuration

Visible particles and/or Tyndall effect (+/−)

Turbidity (FNU)

pH

Particles

Particles

Particles

Particles

0.5 μm/ml

5 μm/ml

10 μm/ml

25 μm/ml

None

Acyclovir alone

-

238 ± 58

3 ± 1

1 ± 0

0 ± 0

-

0.07 ± 0.00

10.03

Ampicillin alone

-

144 ± 50

1 ± 1

0 ± 0

0 ± 0

c+

0.94 ± 0.06

8.87

Ondansetron alone

-

n.d.

n.d.

n.d.

n.d.

-

0.08 ± 0.01

4.21

Paracetamol alonea

-

n.d.

n.d.

n.d.

n.d.

c+

0.59 ± 0.01

5.33

Paracetamol aloneb

-

n.d.

n.d.

n.d.

n.d.

-

0.08 ± 0.00

5.42

Olimel® N5E

Fresh without drug

-

119 ± 63

2 ± 2

1 ± 1

0 ± 1

d+

0.10 ± 0.03

6.30

Acyclovir

0

810 ± 190

37 ± 17

6 ± 3

0 ± 0

++

0.38 ± 0.37

7.80

4

6763 ± 1148

4051 ± 1578

2513 ± 1470

691 ± 679

+++

138.09 ± 211.14

7.63

Ampicillin

0

485 ± 412

4 ± 2

1 ± 0

0 ± 0

e+

0.43 ± 0.12

7.93

4

9550 ± 2285

1 ± 1

0 ± 0

0 ± 0

e+

0.49 ± 0.18

7.81

Ondansetron

0

246 ± 102

1 ± 1

0 ± 0

0 ± 0

-

0.08 ± 0.02

6.22

4

287 ± 84

2 ± 2

0 ± 0

0 ± 0

-

0.08 ± 0.01

6.15

Paracetamol

0

242 ± 104

9 ± 3

1 ± 2

0 ± 0

-

0.10 ± 0.00

6.19

4

153 ± 75

11 ± 6

2 ± 1

0 ± 0

-

0.09 ± 0.01

6.17

Kabiven®

Fresh without drug

-

16 ± 2

0 ± 0

0 ± 0

0 ± 0

d+

0.13 ± 0.03

5.59

Acyclovir

0

3271 ± 2421

410 ± 361

128 ± 98

22 ± 16

++

2.16 ± 1.80

7.18

4

7520 ± 229

6432 ± 211

5163 ± 171

2540 ± 33

+++

683.50 ± 135.06

7.10

Ampicillin

0

157 ± 101

2 ± 1

1 ± 1

0 ± 0

e+

0.61 ± 0.22

7.77

4

3851 ± 2300

2 ± 1

1 ± 1

0 ± 0

e+

0.64 ± 0.18

7.67

Ondansetron

0

103 ± 57

5 ± 1

2 ± 1

0 ± 0

-

0.11 ± 0.01

5.55

4

88 ± 2

2 ± 2

1 ± 2

0 ± 0

-

0.12 ± 0.02

5.55

Paracetamol

0

128 ± 125

1 ± 0

0 ± 0

0 ± 0

-

0.10 ± 0.02

5.56

4

36 ± 23

0 ± 0

0 ± 0

0 ± 0

-

0.10 ± 0.01

5.56

SmofKabiven®

Fresh without drug

-

171 ± 100

5 ± 5

3 ± 3

1 ± 1

d+

0.11 ± 0.03

5.50

Acyclovir

0

650 ± 278

23 ± 8

4 ± 1

0 ± 0

++

0.11 ± 0.02

6.48

4

7088 ± 456

4043 ± 745

2177 ± 697

290 ± 139

+++

86.83 ± 36.60

6.47

Ampicillin

0

505 ± 185

7 ± 6

2 ± 2

0 ± 0

e+

0.26 ± 0.04

7.64

4

2531 ± 1196

3 ± 2

1 ± 1

0 ± 0

e+

0.27 ± 0.04

7.48

Ondansetron

0

172 ± 73

1 ± 1

0 ± 0

0 ± 0

-

0.09 ± 0.01

5.47

4

231 ± 110

1 ± 0

1 ± 0

0 ± 0

-

0.09 ± 0.01

5.49

Paracetamol

0

325 ± 73

2 ± 0

1 ± 0

0 ± 0

f+

0.32 ± 0.01

5.38

4

341 ± 182

1 ± 0

1 ± 0

0 ± 0

f+

0.33 ± 0.01

5.38

  1. a: B. Braun; b: formulations other than B. Braun’s; c: Tyndall effect in pure drug solution, no particles; d: very weak Tyndall effect in pure TPNaq solution, no particles; e: might be a combination of Tyndall effect in pure drug solution and very fine particles; f: probably due to Tyndall effect in pure drug solution and not precipitation
  2. Mean ± standard deviation (n = ≥ 3)